NKGen Biotech Inc (NASDAQ:NKGN) currently has a daily average trading volume of 1.83M but it saw 6066939 shares traded in last market. With a market cap of 34.56M USD, the company’s current market price of $0.77 came falling about -8.66 while comparing to the previous closing price of $0.84. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.06 and as low as $0.20. In the recent trading on the day, stock has struck highest price mark of $0.5852 while lowest mark touched by it was $0.8338.
Taking a look at 20-day trading activity of NKGen Biotech Inc (NKGN) gives us an average price of $0.4997, while its current price level is -81.06% below from 52-week high level whereas it is 279.52% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.5393 while that of 200 days or SMA-200 reads an average of $0.7884. A closer look into the stock’s movement over the week reveals that its volatility is standing at 40.92% during that period while stretching the period over a month that decreases to 17.02%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 66.48 which implies that the stock is in neutral territory.
Over the week, NKGN’s stock price is moving 70.87% up while it is 63.25% when we observe its performance for the past one month. Year-to-date it is 17.35% up and over the past year, the stock is showing a downside performance of -52.54%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, NKGen Biotech Inc’s total number of outstanding shares is 44.95M with 39.40% of that held by the insiders while 17.29% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -118.66%. Stock’s beta reads 0.42. Its return on asset (ROA) is -196.21% on average.
